 | Up a level |
Journal Article
Follows, G., Fischer, K., Bosch, F., Frederiksen, H., Cuneo, A., Ludwig, H., Crompton, N., Maurer, J., Uguen, M., Fingerle-Rowson, G., Hallek, M. and Goede, V. (2016). An updated survival analysis from the CLL11 study in patients with chronic lymphocytic leukaemia treated with obinutuzumab or rituximab in combination with chlorambucil versus chlorambucil alone. Br. J. Haematol., 173. S. 95 - 96. HOBOKEN: WILEY-BLACKWELL. ISSN 1365-2141
Terszowski, G., Crompton, N., Goede, V., Humphrey, K., Lei, G., Klein, C., Mundt, K. and Stern, M. (2016). ASSOCIATION BETWEEN KIR/HLA GENOTYPE AND OUTCOME IN THE CLL11 STUDY OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS RECEIVING CHLORAMBUCIL ALONE OR IN COMBINATION WITH OBINUTUZUMAB OR RITUXIMAB. Haematologica, 101. S. 54 - 56. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078